Literature DB >> 6769799

Isolation, characterization, and biological properties of a tuberculin-active peptidoglycan isolated from the culture filtrate of Mycobacterium tuberculosis.

K C Gupta, S Landi.   

Abstract

A water-soluble tuberculin-active peptidoglycan (TAPG) with a molecular weight of ca. 28,000 to 30,000 was isolated from the culture filtrate of Mycobacterium tuberculosis. TAPG was approximately four to five times more potent than tuberculin purified protein derivative S in guinea pigs sensitized with M. tuberculosis or M. bovis (freeze-dried BCG). It showed little or no cross-reactivity at a dose of 0.1 to 0.4 microgram in guinea pigs sensitized with M. kansasii, M. scrofulaceum, M. intracellulare, or M. avium. TAPG did not show any adjuvant activity when injected in guinea pigs in a water-in-oil emulsion containing ovalbumin. TAPG, in Freund incomplete adjuvant, proved to be an effective immunogen for inducing delayed hypersensitivity in guinea pigs. Chemical analysis of TAPG showed that it contains proline, glutamic acid, alanine, diaminopimelic acid, tyrosine, threonine, glucosamine, and the reducing sugars, arabinose and galactose. In immunoelectrophoretic studies with reference M. tuberculosis H37Rv antiserum, TAPG did not show any precipitin bands.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769799      PMCID: PMC550770          DOI: 10.1128/iai.27.2.344-350.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Isolation, identification, and classification of proteins of tuberculin and the tubercle bacillus.

Authors:  F B SEIBERT; E S FIGUEROA; E H DUFOUR
Journal:  Am Rev Tuberc       Date:  1955-05

2.  Studies on tuberculin active peptide. I. The isolation, crystallization and properties of tuberculin active peptide from tubercle bacillus.

Authors:  S MORISAWA; A TANAKA; K SHOJIMA; Y YAMAMURA
Journal:  Biochim Biophys Acta       Date:  1960-02-26

3.  Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer; L Chedid; A Lamensans; F Parant; M Parant; J P Rosselet; F M Berger
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

4.  The adjuvant active fraction of delipidated mycobacteria.

Authors:  I J Hiu
Journal:  Nature       Date:  1977-06-23       Impact factor: 49.962

5.  Immunoelectrophoretic analysis of antigenic constituents of Seibert fractions of mycobacterial culture filtrates. Identification with the proposed United States-Japan reference nomenclature.

Authors:  T M Daniels; L F Affronti
Journal:  Am Rev Respir Dis       Date:  1973-11

6.  Hydrosoluble adjuvant-active mycobacterial fractions of low molecular weight.

Authors:  D Migliore-Samour; P Jollès
Journal:  FEBS Lett       Date:  1973-09-15       Impact factor: 4.124

7.  A reference system for antigens of Mycobacterium tuberculosis.

Authors:  B W Janicki; S D Chaparas; T M Daniel; G P Kubica; G L Wright; G S Yee
Journal:  Am Rev Respir Dis       Date:  1971-10

8.  The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT.

Authors:  D E Stewart-Tull; T Shimono; S Kotani; M Kato; Y Ogawa; Y Yamamura; T Koga; C M Pearson
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

9.  Ribosomes of acid-fast bacilli: immunogenicity, serology, and in vitro correlates of delayed hypersensitivity.

Authors:  R E Baker; W E Hill; C L Larson
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  1 in total

1.  Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG.

Authors:  S Nagai; J Matsumoto; T Nagasuga
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.